Project description:A panel of 17 human melanoma cell lines with known BRAF and NRAS mutation status was stimulated with TNF-alpha for 72 hours. The goal of the study was to correlate the transcriptional response in BRAF versus NRAS mutated melanoma cell lines. Total RNA was obtained from a panel of 17 human melanoma cell lines treated for 72 hours with TNF-alpha or left untreated. Gene expression profiling was done using the Illumina Human HT12 v4 platform.

2014-02-10 | E-GEOD-51221 | biostudies-arrayexpress

Project description:Illumina RNA-sequencing of MIKK medaka liver samples

| PRJEB43091 | ENA

Targeted RNA Sequencing of a panel of ovarian cancer cell lines

Project description:Assess the baseline expression of the genes in the Oncology Biomarker Panel across the panel of ovarian and cervical cancer cell lines. This data will then be compared to the sensitivity of the cell lines to DDR inhibitors. The expression data will be correlated with the sensitivity of the cell lines to see whether determinants of sensitivity described in the literature translate. A hierarchy of genes will be determined. It is expected that the cells that are more sensitive to DDR inhibitors will have decreased expression of the genes known to be determinants of sensitivity.

2020-05-21 | GSE150942 | GEO

Protein profile in a panel of HEK293A cell lines with genetic deletion

Project description:MS Analysis of genetic KO in a panel of HEK293A cell lines with genetic deletion

2023-03-04 | PXD030368 | Pride

RNA-Seq of a panel of human lymphoma cell lines (B cells)

Project description:We invastigated the baseline transcriptomic profiles of a panel of B-cell lymphoma cell lines

2023-05-10 | GSE221770 | GEO

Project description:Nanopore DNA-seq of MIKK medaka brain samples

| PRJEB43089 | ENA

Identifying beta-catenin interacting proteins in a panel of cell lines

Project description:Affinity purification of beta-catenin interacting proteins with anti-beta-catenin antibody and IgG control in a panel of cell lines: MXP2 (B-ALL), Jeko (Mantle cell lymphoma), Molm13 (AML), Koptk (T-ALL), SW480 (Colorectal) and H446 (Lung).

2025-08-13 | PXD067306 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data